Get started
Author

Jennifer L. Proper

Observed names: Jennifer L Proper, Jennifer Proper, Proper J.L, Proper, Jennifer
ORCID: 0000-0002-6037-4077
Observed ORCID: 0000-0002-6037-4077
OpenAlex ID: A5074005854
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
2022 · Carolyn T. Bramante, Jared D. Huling, et al. · New England Journal of Medicine · 243
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial
2023 · Carolyn T Bramante, John B Buse, et al. · The Lancet Infectious Diseases · 231
PDF
Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles
2021 · Elizabeth R. Lusczek, Nicholas E. Ingraham, et al. · PLoS ONE · 64
PDF
Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19
2024 · Carolyn T Bramante, Kenneth B Beckman, et al. · Clinical Infectious Diseases · 49
PDF
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up
2022 · Carolyn T. Bramante, John B. Buse, et al. · medRxiv · 35
PDF
Morbidity and Mortality Trends of Pancreatitis: An Observational Study
2021 · Nicholas E. Ingraham, Samantha King, et al. · Surgical Infections · 27
Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic Symptoms
2022 · Carolyn T Bramante, Jennifer L Proper, et al. · Open Forum Infectious Diseases · 24
PDF
Sigh Ventilation in Patients With Trauma
2023 · Richard K. Albert, Gregory J. Jurkovich, et al. · JAMA · 22
Metabolite profiles associated with disease progression in influenza infection
2021 · Chris H. Wendt, Sandra Castro-Pearson, et al. · PLoS ONE · 21
PDF
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT Trial
2022 · David R Boulware, Thomas A Murray, et al. · Clinical Infectious Diseases · 14
PDF
Outpatient Treatment of COVID-19 and the Development of Long COVID Over 10 Months: A Multi-Center, Quadruple-Blind, Parallel Group Randomized Phase 3 Trial
2023 · Carolyn Bramante, John B. Buse, et al. · SSRN Electronic Journal · 7
Predicting Probability of Success for Phase III Trials via Propensity-Score-Based External Data Borrowing
2023 · Jennifer L. Proper, Veronica Bunn, et al. · Statistics in Biopharmaceutical Research · 3
Patient Outcomes and Unit Composition With Transition to a High-Intensity ICU Staffing Model: A Before-and-After Study
2023 · Jennifer L. Proper, David A. Wacker, et al. · Critical Care Explorations · 3
Alternative models and randomization techniques for Bayesian response-adaptive randomization with binary outcomes
2021 · Jennifer Proper, John Connett, et al. · Clinical Trials · 3
Network meta analysis to predict the efficacy of an approved treatment in a new indication
2023 · Jennifer L. Proper, Haitao Chu, et al. · Research Synthesis Methods · 2
PDF
Acute Appendicitis Treatment Strategies and Mortality Based on Critical Illness on Admission: An Observational Study
2024 · Samantha King, Jennifer Proper, et al. · Surgical Infections · 1
PDF
An Alternative Metric for Evaluating the Potential Patient Benefit of Response-Adaptive Randomization Procedures
2022 · Jennifer Proper, Thomas A. Murray · Biometrics · 1
PDF
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial
2024 · Boulware D.R., Puskarich M.A, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity over Time in the COVID-OUT Trial
2024 · Nicklas J.M, Klatt N.R, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic Symptoms
2024 · Broedlow C, Sherwood N.E, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
2024 · Lee S., Odde D.J, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
The authors reply
2022 · Ronald A. Reilkoff, Jennifer Proper, et al. · Critical Care Medicine
Works count: 25
Citation count: 981
H-index: 11
I10-index: 11
Year
Topic
Type